Tiny Bubbles in Eye Drops Help Treat Dry Eye Disease

Scientists in China have created a new kind of eye drop that fights dry eye disease much better than regular drops. The new formula uses tiny bubbles filled with a natural plant chemical called kaempferol. These bubbles are packed inside a special gel that sticks to the eye's surface. The gel releases the medicine slowly, giving the eye more time to absorb it. Researchers say this new treatment worked just as well as a popular prescription drug in animal tests.

Dry eye disease is a very common condition that affects people all around the world. People with dry eye often feel burning, itching, or like something is stuck in their eye. In serious cases, the clear front part of the eye — called the cornea — can get damaged. Scientists think the condition is getting more common because people spend so much time staring at screens and because the world's population is getting older.

Kaempferol, sometimes called KAE, is a natural chemical found in many fruits, vegetables, and herbs. It is part of a family of plant chemicals called flavonoids. Scientists have known for a while that KAE can reduce swelling and fight harmful processes in the body called oxidative stress. Studies have shown it may protect eye cells and help repair the surface of the eye. However, KAE has one big problem — it barely dissolves in water, which makes it very hard for eye drops to deliver it where it's needed.

To solve this problem, researchers designed tiny ball-shaped bubbles called niosomes. Each niosome is made from gentle, soap-like materials that are safe for the body. KAE gets tucked inside the bubbles, which protects the medicine and helps carry it into eye tissue. Think of the niosomes like tiny delivery trucks that carry medicine straight to where it needs to go. The bubbles are so small they are measured in nanometers — thousands of times thinner than a human hair.

But the team didn't stop there. They also wrapped the niosome bubbles inside a special gel that reacts to the salty liquid naturally found in tears. When the eye drops touch the eye, the gel quickly becomes thicker and sticks to the eye's surface. This keeps the medicine in place much longer than regular drops, which wash away within minutes. The scientists called their finished formula KAE-NIO-ISG.

One of the biggest challenges with regular eye drops is that the eye flushes them away almost immediately. The eye blinks, tears flow, and most of the medicine drains away before it can work. The new gel-based system gets around this problem by clinging to the surface of the eye. Tests showed the medicine stayed on the eye and was absorbed at levels 23.5 times higher than a plain KAE solution. The highest concentration in the cornea was nearly 36 times greater as well.

The researchers tested the new formula on mice that had been given dry eye disease on purpose. They used a chemical called benzalkonium chloride to damage the surface of the mice's eyes. After the dry eye was confirmed, they treated the mice with different versions of the eye drop for seven days. Mice that got the strongest version of KAE-NIO-ISG produced more tears and had less damage on their corneas. Their eyes also had healthier tissue layers and more goblet cells, which are special cells that help keep the eye moist.

The scientists compared their formula to a well-known prescription drug called cyclosporine A, or CsA. This drug is already used by doctors to treat dry eye disease in people. In the animal tests, the strongest dose of KAE-NIO-ISG worked just as well as CsA. Both treatments reduced levels of two chemicals in the body that cause swelling — called TNF-α and IL-6. Lower levels of these chemicals mean less inflammation and less eye damage.

Safety was also carefully tested. The formula was placed on chicken egg membranes, which are used to check for irritation without harming animals further. It was also tested on living rabbit eyes and on human eye cells in the lab. In every test, the new eye drops caused no damage, no redness, and no irritation. The scientists say this is because the materials used to make the niosomes and the gel are gentle and safe for body tissues.

The researchers believe this new eye drop could one day help millions of people who suffer from dry eye disease. Kaempferol comes from plants, is not an immune-suppressing drug, and appears very safe. This gives it some possible advantages over current treatments for long-term use. The team says more research is needed, including longer safety studies and tests in animals whose eyes are more similar to human eyes. Still, the results so far are very promising, and the scientists are hopeful about taking this treatment closer to human trials.